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Background: On March 19, 2020, the governor of the State of California, Gavin 
Newsom, issued executive stay at home order due to the coronavirus disease (COVID-
19) pandemic (State of California, 2020). In a private psychiatric practice in southern 
California treating patients with anxiety and depression, psychotherapy treatment was 
abruptly affected by that order. The purpose of this project was to transition from onsite 
to online psychotherapy visits to ensure the continuity of care and facilitate patients’ 
progress in dealing with mental illnesses during the COVID-19 crisis. 
Aims: The proposed solution to the problem of decreased access to care during the 
pandemic was to continue psychotherapy in patients with anxiety or depression via 
telepsychiatry, thus contributing to reduced symptomatology. 
Methods: Eight patients participated in the project. Outcome data were collected to 
assess symptoms changes and overall quality of life in patients who received 
psychotherapy treatment for anxiety and/or depression via telepsychiatry. The results 
across patients were assessed after the sixth and twelfth telepsychotherapy sessions. 
Results: Mean patient health questionnaire scores (PHQ-9) decreased 58.5% at midterm 
and 75.5% at final tests and mean general anxiety disorder questionnaire (GAD-7) scores 
decreased 61.3% at midterm and 85.7% at final tests. Mean health related quality of life 
questionnaire (HRQoL-14) scores for unhealthy days decreased 79.7% at final tests. 
Conclusions: This project calls for the need for a practice change by promoting 
telepsychiatry treatment as the gold standard of care for patients with mental illnesses 
during epidemics and other traumatic events restricting access to care. 
3 
 
Keywords: Telepsychiatry, telemental health, telehealth, telemedicine, telepsychology, 
telepsychotherapy, videoconferencing, psychotherapy, depression, anxiety, mental 
illness, pandemic 





Transitioning from Onsite to Online Psychotherapy Visits during the COVID-19 Crisis 
Description of the Clinical Problem 
Mental illness is a medical problem involving changes in emotions, thoughts, and 
behaviors; which may influence an individual’s ability to function effectively and may 
present in many forms with mild to severe symptoms (American Psychiatric Association 
[APA], 2018b). In 2019, the National Alliance on Mental Illness (NAMI) reported that 
millions of people in the United States were affected by mental illness each year and 
estimated that one in five American adults experience mental illness, with one in 25 
experiencing serious mental illness (NAMI, n.d.). According to the World Health 
Organization (WHO), “Mental health conditions are increasing worldwide with a 13% 
rise in the last decade and two of the most common mental health conditions, depression 
and anxiety, cost the global economy $1 trillion each year.” (WHO, n.d.). 
Unfortunately, those with mental illness face multiple challenges including those 
posed by the coronavirus disease (COVID-19) pandemic. On March 4, 2020, the 
governor of the State of California, Gavin Newsom, proclaimed a state of emergency to 
exist in California as a result of COVID-19, and on March 19, 2020, he consequently 
issued executive stay at home order N-33-20 to protect the public health and safety (State 
of California, 2020). The stay-at-home order limited access to mental health care because 
many services had to be stopped abruptly and many practices even had to close their 
doors due to the restrictions generated by the order.  
The COVID-19 pandemic resulted in stress and uncertainty for the entire 
population. For those with mental illness, lack of access to care in this time of stress 
increased their vulnerability and put them at higher risk for deteriorating mental health 
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and other comorbidities, leading, in the worst-case scenario, to suicide. The Centers for 
Disease Control and Prevention (CDC) announced that during a crisis like a pandemic, 
feelings of isolation, depression, anxiety, and other emotional or financial stresses are 
known to increase the risk for suicide, and recommended that people with preexisting 
mental health conditions should continue with their treatment and be aware of new or 
worsening symptoms (CDC, n.d.). 
In a private psychiatric practice in southern California treating patients with 
different types of mental illnesses including anxiety and depression, psychotherapy 
treatment was abruptly affected by the stay-at-home order. Current evidence-based (EB) 
treatments for people with mental illness include psychotherapy or counseling, 
medication, or a combination of both. These are the treatment modalities that have been 
effectively provided in the practice for the management and amelioration of patients’ 
mental health conditions. Therefore, transitioning from onsite to online psychotherapy 
visits was an important strategy to ensure the continuity of care and facilitate patients’ 
progress in dealing with mental illnesses during the COVID-19 crisis. 
Proposed Evidence-based Solutions 
A literature review was conducted using the following nursing and health sciences 
databases: CINAHL, Cochrane Central Register of Controlled Trials, PsycARTICLES, 
PsycINFO, and PubMed. Keywords used for the initial search were telepsychiatry, 
telemental health, telehealth, telemedicine, telepsychology, telepsychotherapy, 
videoconferencing, psychotherapy, depression, anxiety, mental illness, and pandemic. 
The initial search resulted in 14,634 articles. Those articles were then narrowed down to 
full-text articles, published in English in the past 10 years, with a human population, 
6 
 
resulting in 1,159 articles reviewed. A total of 7 articles were selected because they 
demonstrated evidence-based solutions that resulted in increased access to care and 
improved patient outcomes. The levels and types of evidence of the articles were rated 
using John Hopkin’s Appendix D evidence level and quality guide (Dang & Dearholt, 
2017). Six articles were rated as level I-A - randomized controlled trials, systematic 
reviews or meta-analyses, and one was rated as level V-A - literature reviews or opinions 
of nationally recognized experts based on scientific evidence.  
The proposed solution to the problem of decreased access to care during the 
pandemic was to continue psychotherapy in patients with anxiety or depression during 
the COVID-19 crisis via telepsychiatry, thus contributing to reduced symptomatology. In 
their study, Bashshur, Shannon, Bashshur, and Yellowlees (2016) conducted a literature 
review on the effects of telemental health in the treatment of mental illnesses, in which 
they analyzed 25 studies (23 randomized controlled trials [RTCs], one survey, and one 
prospective cohort study). All of the studies focused on health outcomes including 
symptoms and quality of life improvement. Generally, the studies indicated that 
telemental health was an effective treatment for depression and anxiety disorders, 
improved mental healthcare in primary care settings, and improved outcomes when 
patients had comorbid medical conditions. In addition, the studies demonstrated that 
telemental health provided a useful link for patients with special needs and made care 
accessible in areas with limited or no professional mental health resources (Bashshur et 
al., 2016).  
Another study that included 65 reviews and meta-analyses evaluating the efficacy 
of guided and unguided eHealth approaches to psychotherapy, concluded that either 
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guided or unguided eHealth was acceptable to patients and effective in improving 
depression, anxiety, alcohol-related problems, and general mental health compared to 
being on a waitlist for care. In addition, the studies demonstrated that either guided or 
unguided eHealth enhanced traditional psychotherapy treatment by being an adjunctive 
component to it (Bennett, Ruggero, Sever, & Yanouri, 2020). Similarly, a systematic 
review by Harerimana, Forchuk, and O’Regan (2019) analyzed nine studies that 
examined the effects of telehealth provided to older adults with depressive symptoms. 
They concluded that telehealth had a significant impact on health outcomes, including 
reduced depressive symptoms, hospital admissions, and emergency visits, as well as 
improved access to care and better cognitive functioning.  
In another study, Choi et al. (2014) completed an RCT analyzing depression and 
disability outcomes of telehealth problem-solving therapy (PST) provided via skype 
video call compared to in-person PST and telephone care calls for 158 low-income 
homebound older adults. They found both tele-PST and in-person PST were efficacious 
treatments, however, the effects of tele-PST on both depression and disability outcomes 
were sustained significantly longer than those of in-person PST over a six-month period 
following therapy. Effect sizes for the Hamilton rating scale for depression (HAMD) 
score changes at 36 weeks were 0.68 for tele-PST and 0.20 for in-person PST, and effect 
sizes for the World Health Organization disability assessment schedule (WHODAS) 
score changes at 36 weeks were 0.47 for tele-PST and 0.25 for in-person PST (Choi et al., 
2014).  
In another RCT study, Morriss et al. (2019) investigated whether clinical and 
economic outcomes were improved by providing remote cognitive behavioral therapy 
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(RCBT) via videoconferencing or telephone to 156 repeat users of unscheduled care with 
severe health anxiety compared to treatment as usual (TAU). RCBT significantly reduced 
health anxiety scores at 6, 9, and 12 months compared to the TAU group (mean change 
difference HAI = –2.81, 95% confidence interval [CI] = –5.11 to –0.50, P = 0.017). In 
addition, the RCBT group showed significantly greater reductions in generalized anxiety 
at 6 and 12 months and depression at 12 months, and improved overall health at 12 
months (Morriss et al., 2019).  
Finally, the Behavior Therapy Journal published two RCT studies in 2015 that 
evaluated clinical and cost-effectiveness of therapist-guided internet-delivered cognitive 
behavior therapy for older adults with symptoms of anxiety and depression. These studies 
indicated that the treatment groups had significantly lower general anxiety disorder 
questionnaire (GAD-7) and patient health questionnaire (PHQ-9) scores than the waitlist 
control groups ( p < .001) at the end of treatment. In addition, the GAD-7 and PHQ-9 
scores of the treatment groups post-treatment and at 3 and 12 months were all 




The Iowa model of evidence-based practice (EBP) is a practice model that guides 
clinicians in the use of evidence to improve health care outcomes (Rycroft-Malone & 
Bucknall, 2010). This model has been validated as a practical tool for the EBP process 
across diverse settings. It links practice changes within the system and promotes 
excellence in health care (Buckwalter et al., 2017). The Iowa model has the major 
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strengths of guiding the process of applying evidence in practice, addressing how to 
select priority EBP topics, and facilitating project implementation and evaluation of 
resulting changes in patient and/or staff outcomes. Decision points in the model assist in 
driving the process forward (Bliss-Holtz, 2007). The Iowa model is appropriate for 
various health care disciplines including physicians, nurses, physical therapists, and allied 
health personnel (Rycroft-Malone & Bucknall, 2010).  
The Iowa model was chosen because it provided valuable tools that guided 
implementation of the project, beginning with identification of a clinical problem and 
generation of a practice question that led to piloting a practice change and evaluation of 
its effects on patient outcomes. The main goals of the project were to maintain access to 
mental health care services and to decrease levels of anxiety and/or depression 
experienced by clients by providing online EB psychotherapy treatment during the 
COVID-19 crisis. 
Project Approval 
The project proposal was presented by the project leader to the lead psychiatrist of 
a private psychiatric practice and the project leader’s faculty advisor via remote 
technology to discuss the identification of the problem, background information, data 
found in literature reviews, the purpose of the study, its importance, its design, and the 
process for the implementation. Consequently, the project was approved by both of them, 
whose letters of approval were then obtained. As a result, an application letter for 
approval was then submitted to the University of San Diego (USD) Institutional Review 
Board (IRB) entity. The application letter would have preferably been submitted in 
person, but due to the COVID-19 restrictions, the letter was submitted via email. The 
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project leader submitted the application letter for approval and received guidance from 
USD faculty advisor. Once the project was approved by the IRB, the project was 
implemented. 
Stakeholder Identification 
This EBP project consisted of two types of stakeholders; process stakeholders and 
outcome stakeholders. The process stakeholders are the ones who would want updates of 
the project and, thus, received updates on a weekly or monthly basis. The outcome 
stakeholders are the ones who would be interested in the results of the project and, thus, 
were informed of the results at the end of the project after its six-month timeframe. The 
person responsible for communicating all updates and results of the project to all 
stakeholders was the project leader. 
Process stakeholders consisted of USD IRB entity, lead psychiatrist, and project 
leader’s faculty advisor. The lead psychiatrist received weekly email updates regarding 
the project and met with the project leader via monthly videoconference or telephone 
meetings at which updates and recommendations were discussed. The project leader’s 
faculty advisor received electronic weekly updates on the project and also met with the 
project leader on a monthly or bi-monthly basis via videoconference. Outcome 
stakeholders consisted of patients receiving telepsychotherapy, the USD IRB, practice 
providers, and other mental health professionals. The final results were presented at a 
stakeholders’ presentation at the practice and at the USD Doctor of Nursing Practice 
(DNP) project presentation day. 
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Description of EBP Project, Facilitators & Barriers 
The objective of this EBP project was to transition the utilization of onsite 
psychotherapy treatment into online psychotherapy to help maintain access to mental 
health care services and to continue reducing the severity of symptoms for patients with a 
diagnosis of anxiety and/or depression at a private psychiatric practice during the 
COVID-19 Crisis. The project leader provided EB psychotherapy treatments, such as 
cognitive behavioral therapy (CBT), supportive psychotherapy, and counseling, via 
telepsychiatry. Telepsychiatry, also known as telemedicine, telehealth, telemental health, 
and telepsychology, is a general term referring to the delivery of mental health care 
services at a distance via videoconferencing or telephone. According to the APA (2018a), 
telepsychiatry using video conferencing is a validated and effective practice of 
psychiatric medicine that increases access to care. Therefore, for the purpose of this 
project, telepsychiatry was provided via video using Zoom technology by means of 
which the patient and the project leader were able to see each other for individual 
psychotherapy using their own computers or cellphone devices.  
The EBP project took place over 6 months from June to November of 2020. 
Patients with a diagnosis of anxiety and/or depression and in need to start CBT treatment, 
were initially informed by lead psychiatrist that psychotherapy treatment was going to 
continue to be available to them via telepsychiatry in order to maintain continuity of care 
and achievement of desired clinical outcome. During the timeframe of the project, lead 
psychiatrist recommended eight patients to participate in the project, and thus, all eight 
were selected. Therefore, patients’ severity of depression and/or anxiety was assessed 
using the PHQ-9 questionnaire or the GAD-7 questionnaire, respectively, before the 
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initial telepsychotherapy session, at midterm after their sixth session, and at the end after 
their 12th session. In addition, patients’ quality of life was evaluated using the health-
related quality of life questionnaire (HRQOL-14), before their initial telepsychotherapy 
session and after the twelfth session. All data were gathered by the project leader who 
compared them across the three time periods. 
Facilitators for this project included the lead psychiatrist who is also the project 
leader’s mentor, the support of the University of San Diego (USD) Hahn School of 
Nursing and Health Science, and the project leader’s faculty advisor. Besides, increasing 
the knowledge of patients and their families by educating them about the positive results 
of EB psychotherapy treatments via telepsychiatry would add them also as key 
facilitators for this project. Barriers include patients’ resistance to change, resistance due 
to the stigma of mental illness, and patients’ noncompliance. To overcome these barriers, 
studies resulting in improved patients’ outcomes by the use of EB psychotherapy 
treatments were presented and explained to patients via Zoom technology. In addition, 
weekly emails and video calls were provided to patients to encourage their participation 
and compliance. 
Process Indicator Data Monitoring 
This EBP project consisted of different process indicators that were monitored 
during the implementation of the project. Initially, educating about telepsychotherapy for 
the treatment of anxiety and/or depression was provided to patients; before and during the 
implementation of the project. This was achieved by providing educational handouts via 
email and Zoom technology. One process indicator included the number of weekly 
emails sent to patients to remind them of the tools and skills learned in the psychotherapy 
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sessions and to motivate their participation. A second process indicator was the number 
of weekly or biweekly telepsychotherapy sessions conducted. In addition, psychotherapy 
sessions were monitored by the lead psychiatrist for quality of practice. Finally, patients’ 
follow-up appointments were monitored for no-shows or cancelations to ensure patients 
got rescheduled and, thus, were able to continue receiving consistent treatments. These 
data were monitored daily to facilitate rescheduling as needed. 
Outcome Indicator Data Monitoring 
This EBP project additionally consisted of outcome indicators that are known to 
be used for monitoring the results of interventions used in a project. Project outcome 
indicators included patients’ anxiety or depression scores; collected monthly using the 
GAD-7 and PHQ-9 questionnaires, respectively. These questionnaires were collected via 
email after they were completed by patients prior to their initial psychotherapy session 
and after their sixth and twelfth session. Initial data were collected at the beginning of the 
project and were compared to data collected after to assess symptom changes.  
HRQoL-14 questionnaires were used as another outcome indicator to assess the 
effect of telepsychotherapy on patients’ functionality and quality of life. These data were 
also collected before receiving telepsychotherapy and after patients’ twelfth 
psychotherapy sessions, when patients described their overall health when compared to 
their health before participating in this project. 
Data Analysis and Results 
Data Analysis 
Outcome data were collected to assess symptoms changes and overall quality of 
life in patients who received psychotherapy treatment for anxiety and/or depression via 
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telepsychiatry. The results were analyzed for each patient after the sixth and twelfth 
telepsychotherapy sessions, and the final results across patients were assessed at the end 
of the project’s six-month timeframe. 
Project Participation 
A total of eight patients participated in the project - seven Hispanic females and 
one Hispanic male between the ages of 31 and 58. Four patients were being treated for 
depression and all had a diagnosis of anxiety. Telepsychotherapy sessions were 
conducted in Spanish and English, as per patients’ preferences, and all patients completed 
the 12 psychotherapy sessions via telepsychiatry. 
Project Outcomes 
At the midterm and final telepsychotherapy, there were significant improvements 
noted across all outcome measures. Mean PHQ-9 scores for the four patients with 
depression demonstrated a 58.5% decrease from the initial tests (M = 13.25) to midterm 
tests (M = 5.5), and a 75.5% decrease in mean scores from the initial tests to the final 
tests (M = 3.25); indicating significant improvements from moderate and moderately 
severe depression to mild and minimal depression across all subjects (Figure 1).  
Across all patients, mean GAD-7 scores for anxiety demonstrated a 61.3% 
decrease in mean scores from the initial tests (M = 14.87) to midterm tests (M = 5.75), 
and an 85.7% decrease in mean scores from the initial tests to the final tests (M = 2.12) 
also indicating significant improvements from moderate and severe anxiety to mild and 
minimal anxiety across all subjects (Figure 2).  
Furthermore, significant improvements in the number of reported unhealthy days 
were seen across all subjects after evaluating and comparing the HRQoL scores from 
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their initial and final questionaries (Figure 3). Across all patients, mean HRQoL scores 
for unhealthy days demonstrated a 79.7% decrease from the initial tests (M = 19.75) to 
the final tests (M = 4).  
Figure 1  

























Patient 4 Patient 5 Patient 6 Patient 8
Mean Score Reduced by 58.5% at Midterm & 75.5% at Final
Initial Mean Score: 13.25 Midterm Mean Score: 5.5 Final Mean Score: 3.25
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Figure 2  
General Anxiety Disorder Questionnaire (GAD-7) Scores for Anxiety 
 
Figure 3  
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There were no costs associated with this EBP project. The project leader, who 
is a Doctor of nursing practice (DNP) psychiatric mental health nurse practitioner 
(PMHNP) student, volunteered his time as a therapist to provide therapy sessions to all 
patients included in this project. The cost to deliver therapy includes the cost of using the 
Zoom application plus the therapist’s time. There was no cost for the use of the Zoom 
application as this was a free application, and the cost for the therapist’s time would have 
been $65 per hour. He provided a total of 77 hours of therapy; equating to a total cost of 
$5,005 for the therapist’s time. However, since this was a volunteered time, the cost was 
considered as savings instead. Copies of the CBT worksheets, PHQ-9, GAD-7, and 
HRQoL-14 forms did not create any cost either as they all were sent and filled out 
electronically.  
In the United States in 2010, 15,446,771 people were estimated to have major 
depressive disorder (MDD) and the financial hardship of this disorder was calculated to 
be $210.5 billion (Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015). In addition, 
WHO (2016) calculated that the number of people suffering from depression and/or 
anxiety increased by almost 50% from $416 million to $615 million between 1990 and 
2013, and also estimated that, during emergencies, such as the COVID-19 pandemic, as 
many as 1 in 5 people are affected by depression and/or anxiety. Failure to provide 
effective treatment of mental illnesses such as depression and anxiety is known to 
increase the risk for other comorbidities, thus resulting in a more costly financial burden. 
Therefore, implementing this EBP project not only reduced the costs caused by these 
disorders but also resulted in attaining higher-quality, longer lives free of preventable 
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disability, which is one of the goals of Healthy People 2020. Estimates of the costs and 
benefits of the project are provided in Table 1. 
Table 1 
DNP Project – Cost-Benefit Analysis 
Resources Cost Rationale 
Cost to deliver therapy: 
Cost of Zoom application 
plus therapist’s time 
($65/hour) 
Cost of Zoom: $0.00 
Therapist time: $65.00 x 
77 hours = ($5,005) 
Considered instead as cost 
savings since this was 
volunteered time 
PHQ-9, GAD-7, and  
HRQoL-14 Questionnaires, 
and CBT worksheets: 128 
copies 
$0.00 Forms sent and filled out 
electronically 
Benefits Cost Rationale 
15,446,771 MDD cases x 
$13,627.44 in treatment 
cost per case 
$210.5 billion This DNP project helped 
reduce the yearly cost of 
depression 
People suffering from 
depression and/or anxiety 
between the years 1990 and 
2013 
Increased by almost 50% 
from $416 million to $615 
million 
This DNP project helped 
reduce the yearly cost of 
depression and anxiety 
Invaluable benefits Improved severity of symptoms of depression and anxiety 
Improved functionality and quality of life 
Improved access to mental health care during the COVID-
19 pandemic 
 
Implications for Research and Practice 
Project Impact  
Telepsychiatry treatment is fundamental for the continued management of mental 
illnesses during the COVID-19 crisis. This project improved patient outcomes. 
Continuity of care was maintained, while patients and families acquired increased 
knowledge of the EB treatments available to them. In addition, patients exhibited 
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improved symptoms, functionality, and quality of life as measured by the HRQoL, PHQ-
9, and GAD-7 screening tools. 
Sustainability 
As the main goal of this EBP project was to improve patient outcomes and access 
to mental health care, the new practice change must remain sustained until it is possible 
to return to in-person care. The first step to ensure the sustainability of this project is to 
continue seeing patients via telepsychiatry during the COVID-19 restrictions and to 
continue collecting HRQol-14, GAD-7, and PHQ-9 questionnaires monthly and compare 
them every 6 months. This should be done to continue access to mental health care and to 
continue monitoring symptom severity and quality of life. The second step to ensure 
sustainability is to standardize access to mental health care during the COVID-19 
restrictions and other similar events via telepsychiatry. This should be accomplished by 
having an accessibly written guideline to telepsychiatry for all clinicians, with a list of all 
the different types of psychiatric-mental health treatments that can be provided to patients 
via telepsychiatry. Continued monitoring of outcome measures and standardizing the 
treatment of mental illness via telepsychiatry during the similar catastrophic events can 
improve mental health care and its effectiveness. 
Conclusions 
Abrupt discontinuation of access to mental health care services presents various 
clinical problems in the management of mental illnesses, including worsening of 
symptoms and poor long-term outcomes. The telepsychiatry intervention used in this 
project demonstrated that mental illnesses can be managed efficiently and effectively via 
distance mechanisms. It can also be concluded that providing psychotherapy via 
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telepsychiatry has been successful not only in decreasing symptomatology, but also in 
improving functionality and quality of life in patients with depression and/or anxiety. 
This EBP project calls for the need for a practice change by promoting telepsychiatry 
treatment as the gold standard of care for patients with mental illnesses during epidemics 
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